z-logo
open-access-imgOpen Access
Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer
Author(s) -
Mark A. Lewis,
Lynn C. Hartmann,
Daniel H. Lachance,
Rafael E. Jiménez
Publication year - 2010
Publication title -
rare tumors
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.285
H-Index - 15
eISSN - 2036-3613
pISSN - 2036-3605
DOI - 10.4081/rt.2010.e42
Subject(s) - opsoclonus , medicine , neuroblastoma , context (archaeology) , lung cancer , population , paraneoplastic cerebellar degeneration , pathology , immunology , antibody , autoantibody , paleontology , genetics , environmental health , biology , cell culture
Paraneoplastic opsoclonus is well described in neuroblastoma. In the adult oncologic population, opsoclonus is seen usually within the context of opsoclonus–myoclonus ataxia and is associated most strongly with small-cell lung cancer. Patients with paraneoplastic opsoclonus are often seronegative. Patients with gynecologic malignancies are known to be predisposed to paraneoplastic syndromes; however, we describe the first case of paraneoplastic opsoclonus in association with endometrial cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom